CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- SC TO-C Deal Written Communication Relating to an Issuer
- SC TO-C Deal Written Communication Relating to an Issuer
- 8-K Event Other events
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Grant or award EVP, US Pharma acquired 30,847 shares (grant or award)
- 4 Shares withheld for taxes EVP, US Pharma gave up 22,736 shares (to pay taxes)
- 4 Grant or award SVP, Controller & CAO acquired 27,371 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Grant or award Director acquired 9,384 shares (grant or award)
- 4 Grant or award Director acquired 4,034 shares (grant or award)
- 4 Grant or award Director acquired 1,032 shares (grant or award)
- 8-K Event Material agreement · New debt or obligation · Other events
- 8-K Event Other events
- 4 Open-market buy Director bought 3,564,059 shares at $5.94 ($21,170,510)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 2,788,608 shares at an average $5.27 ($14,700,257)
- 8-K Event Other events
- SD Other Specialized Disclosure
- SCHEDULE 13D/A Stake Beneficial Ownership Report
Page 6 of 121 · 2,419 filings